Biocartis Group NV (EBR:BCART)
0.2900
0.00 (0.00%)
At close: Aug 1, 2025, 5:30 PM CET
Biocartis Group NV Revenue
In the year 2023, Biocartis Group NV had annual revenue of 47.69M EUR, down -17.74%. Biocartis Group NV had revenue of 29.62M in the half year ending June 30, 2023, with 28.45% growth.
Revenue
47.69M
Revenue Growth
-18.19%
P/S Ratio
0.57
Revenue / Employee
90.67K
Employees
526
Market Cap
27.24M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 47.69M | -10.29M | -17.74% |
Dec 31, 2022 | 57.98M | 3.08M | 5.61% |
Dec 31, 2021 | 54.90M | -661.00K | -1.19% |
Dec 31, 2020 | 55.56M | 17.83M | 47.25% |
Dec 31, 2019 | 37.73M | 9.08M | 31.70% |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UCB SA | 6.15B |
argenx SE | 2.45B |
Financière de Tubize | 13.26K |
Fagron NV | 871.96M |
Ion Beam Applications | 498.16M |
Nyxoah | 4.36M |
Onward Medical | 1.74M |
Hyloris Pharmaceuticals | 9.76M |